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We read with interest the editorial by Veldhuijzen van Zanten
and Kitas [1], in which they consider whether carotid artery
intima-media thickness (IMT) - a surrogate marker of athero-
sclerosis - might be a good predictor of future cardiovascular
events in patients with rheumatoid arthritis (RA). They state
that it remains an open question, because no long-term
studies have documented such an association in patients
with RA. We are pleased to provide the readers of this journal
with an answer to this question.
We recently reported [2] that carotid artery IMT had good
ability to predict development of cardiovascular events over a
5-year period of follow up in 47 patients with RA without
clinically evident cardiovascular disease at the time of
evaluation by carotid ultrasonography. In our study carotid
IMT, categorized in quartiles, was strongly associated with
cardiovascular events; specifically, none of the RA patients
with carotid IMT less than 0.77 mm suffered cardiovascular
events. However, six of the 10 patients with carotid IMT
greater than 0.91 mm experienced cardiovascular events.
When logistic regression models were performed, carotid
IMT at the time of ultrasonographic study had high power to
predict development of cardiovascular events over the 5-year
period of follow up. Although the area under the receiver
operating characteristic curve was 0.86 when using age at
the onset of the study, it was greater in models that included
carotid IMT. In this regard, the area under the receiver
operating characteristic curve was 0.93 for a model that
included only carotid IMT. Based on these findings, we
propose that ultrasonographic assessment of the carotid
artery should be performed in all patients with RA in order to
identify the subgroup of patients at high risk for cardio-
vascular complications.
In the same editorial, Veldhuijzen van Zanten and Kitas [1]
emphasize that endothelial function is highly dependent on
current levels of inflammation. We agree entirely with the
authors on this point; we observed endothelial dysfunction in
patients with biopsy-proven giant cell arteritis (GCA) - an
inflammatory disease that involves large and middle-sized
blood vessels. However, steroid therapy was able to improve
endothelial function. This effect was observed when labora-
tory markers of inflammation returned to normal levels [3].
Whether normalization of endothelial function might lead to
‘protection’ against development of accelerated athero-
sclerosis in chronic inflammatory diseases remains to be
determined, but this is in intriguing possibility. It could explain
why GCA mortality in very distant regions (such as
Rochester, Minnesota, USA and Lugo, north west Spain) is
comparable to that observed in the general population of the
same age [4]. In this regard, we recently reported that the
carotid IMT was not increased in biopsy-proven GCA
patients who had ended steroid therapy compared with
matched control individuals from the same population [5].
Letter
Carotid intima-media thickness and endothelial function: 
useful surrogate markers for establishing cardiovascular risk 
in patients with inflammatory rheumatic disease
Miguel A Gonzalez-Gay1,2, Carlos Gonzalez-Juanatey3, Tomas R Vazquez-Rodriguez2, 
Javier Martin4 and Javier Llorca1,5,6
1MAG-G and JL are senior authors
2Division of Rheumatology, Hospital Xeral Calde, c) Dr Ochoa s/n, 27004, Lugo, Spain
3Division of Cardiology, Hospital Xeral Calde, c) Dr Ochoa s/n, 27004, Lugo, Spain
4Consejo Superior de Investigaciones Cientificas, Avenida del Conocimiento s/n, 18100, Armilla, Granada, Spain
5Division of Epidemiology and Computational Biology, School of Medicine, University of Cantabria, Avda. Cardenal Herrera Oria s/n, 39011,
Santander, Spain
6CIBER Epidemiología y Salud Pública (CIBERESP), Spain
Correspondence: Miguel A Gonzalez-Gay, miguelaggay@hotmail.com
Published: 16 May 2008 Arthritis Research & Therapy 2008, 10:403 (doi:10.1186/ar2409)
This article is online at http://arthritis-research.com/content/10/3/403
© 2008 BioMed Central Ltd
See related editorial by Veldhuijzen van Zanten and Kitas, http://arthritis-research.com/content/10/1/102 
and related response by Veldhuijzen van Zanten and Kitas, http://arthritis-research.com/content/10/3/404
GCA = giant cell arteritis; IMT = intima-media thickness; RA = rheumatoid arthritis.Page 2 of 2
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Taking all of these considerations into account, we support
the use of surrogate markers to determine the cardiovascular
risk of patients with inflammatory rheumatic diseases.
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